FN1 and atherosclerosis: Recent studies have confirmed that EndMT is prevalent during atherosclerosis (AS), driving its progression by increasing the deposition of fibronectin (18) and adhesion molecules, as well as altering the balance of collagen and matrix metalloproteinases (19).